Investment Stage

Focus Areas

About Investor

Di Wang is a Partner at Source Code Capital, specializing in Medical Devices investments from Seed through Series B. She focuses on innovative healthcare technologies that improve patient outcomes and clinical efficiency. Di works closely with founders on product development, regulatory strategy, fundraising, and commercialization. Her investment experience includes evaluating emerging medical technologies with strong scientific foundations. She supports portfolio companies as they scale across healthcare markets in China and internationally. Her investment philosophy centers on backing medical innovations capable of delivering meaningful clinical and commercial impact.